I read this as CART is feasible in r/r BL and could serve as a bridge to allogeneic transplant given encouraging CR rates but short duration of response.

I said: Revumenib in AML and Dara in SMM. I got an email that I need to expand on these. I said that they weren't there and now they are so I can use them. I get the above email that "ASH Reviewers" denied my CME.

Absolutely bonkers!

Also, HTN as the reason for being anthracycline ineligible in 80% is fairly arguable.

Is Amer Zidan here?